Digital Mindfulness Therapy for Obsessive-Compulsive Disorder
Official title: Effects and Neurophysiological Mechanisms of Digital Mindfulness-Based Therapy for Obsessive-Compulsive Disorder
Run by Central South University · NCT07701616 · Data updated 2026-11-12
A 6-week digital mindfulness program is being tested to see if it helps people with OCD, either alone or with standard OCD medication, compared with medication alone.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 12 Years to 65 Years |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | Central South University Academic / other |
| Locations | 2 sites (Changsha, Hunan and 1 other locations) |
| Status | Recruiting |
| Started | July 15, 2026 |
| Main results expected | September 1, 2027 |
| Study ends | October 31, 2028 |
| Registry record updated | July 20, 2026 |
| Trial ID | NCT07701616 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Individuals aged 12–65 with a primary OCD diagnosis, able to consent, and either not on unstable medication or willing to maintain stable treatment for a period before and during the study.
✕Probably not a fit
Patients with schizophrenia spectrum, bipolar, substance use, or personality disorders, or those with severe physical/CNS illness may not benefit or participate safely.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized trial will enroll 150 participants with obsessive-compulsive disorder and assign them equally to three groups: digital mindfulness-based therapy (MBT) alone, routine pharmacological treatment, or MBT plus pharmacological treatment. The MBT is delivered via a mobile mini-program with video and audio lessons, guided practices, supervised weekly learning, and home exercises over six weeks. Participants will be assessed at baseline, during the 6-week program, and at 1, 3, 6, and 12 months to measure changes in OCD symptom severity and explore potential psychological and neurophysiological mechanisms. The study will examine whether MBT can provide an accessible, standardized psychological intervention either as a standalone treatment or in combination with medication.
Why it matters
Potential benefit: If successful, MBT could offer a convenient, scalable option to reduce OCD symptoms and improve treatment access.
How similar studies have gone: Prior digital psychological interventions have shown promise in OCD and related disorders, though results vary and this specific tripartite design is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. A primary diagnosis of obsessive-compulsive disorder according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). 2. Aged 12 to 65 years. 3. Primary school education or above and able to understand the study procedures and complete the required assessments. 4. Willing and able to provide written informed consent. For participants under 18 years of age, written informed consent will also be obtained from a parent or legal guardian. 5. Participants who are already receiving psychotropic medication must have maintained a stable medication regimen for at least 4 weeks before enrollment. Any clinically necessary medication changes during the study will be documented. Exclusion Criteria: 1. Current or lifetime diagnosis of schizophrenia spectrum disorder, bipolar disorder, substance use disorder, or personality disorder. 2. Severe physical illness or central nervous system disease that may interfere with participation in the study. 3. Severe suicidal ideation or suicidal behavior within the past month. 4. Pregnancy, planned pregnancy, or breastfeeding. 5. Concurrent participation in another psychotherapy program or clinical trial. 6. Mindfulness practice within the past month. 7. Inability to understand or comply with the study procedures.
Where it's running
-
The Second Xiangya Hospital of Central South University
Changsha, Hunan, China Recruiting -
The Third Xiangya Hospital of Central South University
Changsha, Hunan, China Recruiting
Study contacts
- Study coordinator: Chen Pan, Dr
- Email: 758933968@qq.com
- Phone: 86-0731-88618487
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Low-intensity focused ultrasound targeting the subthalamic nucleus for OCD
A short test is being done to see if a wearable, non-invasive ultrasound device can safely and tolerably help adults with OCD by targeting a brain region called the subthalamic nucleus.
-
Mindfulness-Based Cognitive Therapy for OCD Delivered Online
This study tests a synchronous online MBCT program for adults with OCD to see if it is acceptable and feasible and to explore links between biological markers, OCD severity, and treatment response.
-
Targeted brain stimulation for OCD: test of tTIS on nucleus accumbens
This study tests whether targeted temporal interference stimulation of the nucleus accumbens can help reduce obsessive-compulsive symptoms in adults with OCD, compared with sham stimulation.
-
Anxiety Skills Study: See if video skill training plus therapy helps people with anxiety
This study tests whether a brief video-based skill training can help people with anxiety as well as four therapy sessions, and how durable the effects are over a year.
-
AttunE LIFU for OCD: a non-invasive brain stimulation study
This trial tests ATTN201, a wearable ultrasound headband, to see if it helps adults with OCD compared to a sham treatment.
-
Combined ERP and Habit Reversal Therapy for Tourettic OCD
This study tests whether a merged Exposure and Response Prevention and Habit Reversal Therapy helps adults with Tourettic OCD more than either therapy alone or basic psychoeducation.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.